Adiso Therapeutics

Concord, United States

Adiso Therapeutics develops medications to treat inflammatory diseases.

$60.0M raised

Mar 2022

Series A

Biotechnology Health Care Medical Medical Device Therapeutics

Top Investors

Morningside

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Adiso Therapeutics

How much funding has Adiso Therapeutics raised?

Adiso Therapeutics has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in March 2022.

Who are Adiso Therapeutics's investors?

Adiso Therapeutics's investors include Morningside.

Where is Adiso Therapeutics headquartered?

Adiso Therapeutics is headquartered in Concord, United States.

What does Adiso Therapeutics do?

Adiso Therapeutics develops medications to treat inflammatory diseases.

What stage is Adiso Therapeutics at?

Adiso Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2022.

MLA

"Adiso Therapeutics — Funding & Investors." VCBacked, March 10, 2022, https://www.vcbacked.co/company/adiso-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Adiso Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/adiso-therapeutics

Wikipedia (cite web)

{{cite web |title=Adiso Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/adiso-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K